大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/15 | 4,750 | 4,801 | 4,731 | 4,790 | +37 | +0.8% | 701,400 |
2021/06/14 | 4,750 | 4,759 | 4,719 | 4,753 | +23 | +0.5% | 601,600 |
2021/06/11 | 4,696 | 4,747 | 4,670 | 4,730 | +35 | +0.7% | 1,125,500 |
2021/06/10 | 4,625 | 4,707 | 4,623 | 4,695 | +44 | +0.9% | 746,300 |
2021/06/09 | 4,670 | 4,678 | 4,617 | 4,651 | -2 | ±0% | 536,800 |
2021/06/08 | 4,650 | 4,672 | 4,600 | 4,653 | +52 | +1.1% | 880,900 |
2021/06/07 | 4,619 | 4,660 | 4,578 | 4,601 | -3 | -0.1% | 643,400 |
2021/06/04 | 4,603 | 4,610 | 4,554 | 4,604 | +29 | +0.6% | 742,700 |
2021/06/03 | 4,560 | 4,618 | 4,551 | 4,575 | +60 | +1.3% | 924,400 |
2021/06/02 | 4,415 | 4,548 | 4,360 | 4,515 | +35 | +0.8% | 1,037,800 |
2021/06/01 | 4,547 | 4,549 | 4,455 | 4,480 | -36 | -0.8% | 492,800 |
2021/05/31 | 4,580 | 4,594 | 4,512 | 4,516 | -90 | -2% | 687,400 |
2021/05/28 | 4,586 | 4,635 | 4,563 | 4,606 | +49 | +1.1% | 1,482,700 |
2021/05/27 | 4,475 | 4,560 | 4,465 | 4,557 | +80 | +1.8% | 2,599,200 |
2021/05/26 | 4,424 | 4,495 | 4,416 | 4,477 | +7 | +0.2% | 932,600 |
2021/05/25 | 4,493 | 4,494 | 4,446 | 4,470 | ±0 | ±0% | 937,800 |
2021/05/24 | 4,413 | 4,502 | 4,411 | 4,470 | +38 | +0.9% | 616,300 |
2021/05/21 | 4,427 | 4,456 | 4,407 | 4,432 | +45 | +1% | 796,300 |
2021/05/20 | 4,395 | 4,422 | 4,370 | 4,387 | -52 | -1.2% | 695,100 |
2021/05/19 | 4,405 | 4,456 | 4,369 | 4,439 | -22 | -0.5% | 917,100 |
2021/05/18 | 4,439 | 4,487 | 4,411 | 4,461 | +46 | +1% | 886,700 |
2021/05/17 | 4,400 | 4,427 | 4,371 | 4,415 | +26 | +0.6% | 613,500 |
2021/05/14 | 4,231 | 4,416 | 4,230 | 4,389 | +171 | +4.1% | 1,084,500 |
2021/05/13 | 4,243 | 4,268 | 4,195 | 4,218 | -30 | -0.7% | 779,900 |
2021/05/12 | 4,288 | 4,306 | 4,210 | 4,248 | -32 | -0.7% | 753,600 |
2021/05/11 | 4,375 | 4,396 | 4,259 | 4,280 | -104 | -2.4% | 879,600 |
2021/05/10 | 4,323 | 4,391 | 4,323 | 4,384 | +87 | +2% | 624,200 |
2021/05/07 | 4,267 | 4,338 | 4,245 | 4,297 | +38 | +0.9% | 762,500 |
2021/05/06 | 4,276 | 4,309 | 4,247 | 4,259 | +58 | +1.4% | 1,099,100 |
2021/04/30 | 4,195 | 4,231 | 4,182 | 4,201 | -16 | -0.4% | 893,600 |
2021/04/28 | 4,204 | 4,240 | 4,183 | 4,217 | -26 | -0.6% | 785,900 |
2021/04/27 | 4,330 | 4,333 | 4,241 | 4,243 | -69 | -1.6% | 905,300 |
2021/04/26 | 4,294 | 4,335 | 4,262 | 4,312 | -11 | -0.3% | 784,200 |
2021/04/23 | 4,278 | 4,333 | 4,273 | 4,323 | +24 | +0.6% | 737,700 |
2021/04/22 | 4,278 | 4,304 | 4,232 | 4,299 | +55 | +1.3% | 815,300 |
2021/04/21 | 4,231 | 4,254 | 4,195 | 4,244 | -33 | -0.8% | 1,035,200 |
2021/04/20 | 4,329 | 4,335 | 4,269 | 4,277 | -75 | -1.7% | 828,300 |
2021/04/19 | 4,330 | 4,368 | 4,316 | 4,352 | +28 | +0.6% | 578,300 |
2021/04/16 | 4,362 | 4,365 | 4,324 | 4,324 | +13 | +0.3% | 829,000 |
2021/04/15 | 4,379 | 4,386 | 4,311 | 4,311 | -53 | -1.2% | 995,400 |
2021/04/14 | 4,500 | 4,500 | 4,357 | 4,364 | -206 | -4.5% | 1,584,300 |
2021/04/13 | 4,536 | 4,611 | 4,536 | 4,570 | +34 | +0.7% | 678,000 |
2021/04/12 | 4,557 | 4,572 | 4,524 | 4,536 | +20 | +0.4% | 671,500 |
2021/04/09 | 4,525 | 4,565 | 4,484 | 4,516 | +34 | +0.8% | 1,077,700 |
2021/04/08 | 4,570 | 4,572 | 4,475 | 4,482 | -83 | -1.8% | 690,000 |
2021/04/07 | 4,575 | 4,605 | 4,532 | 4,565 | -15 | -0.3% | 610,700 |
2021/04/06 | 4,693 | 4,704 | 4,576 | 4,580 | -86 | -1.8% | 778,100 |
2021/04/05 | 4,702 | 4,715 | 4,646 | 4,666 | -15 | -0.3% | 663,800 |
2021/04/02 | 4,715 | 4,726 | 4,656 | 4,681 | -4 | -0.1% | 471,500 |
2021/04/01 | 4,740 | 4,760 | 4,677 | 4,685 | -2 | ±0% | 641,200 |
951~
1000
件表示中 / 3518件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム